Study to Assess the Burden of Mild Outcomes (Physician Office Visits) Due to Influenza in the United States
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Influenza
Related studies linked through entity extraction aliases.
Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention
- Status
- UNKNOWN
- Phase
- PHASE1
Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With Influenza
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety and Immunogenicity of Co-administration of Candidate Influenza Vaccine MVA-NP+M1 and Viroflu® Seasonal Influenza Vaccine
- Status
- TERMINATED
- Phase
- PHASE1
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
- Status
- COMPLETED
- Phase
- PHASE1
Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults
- Status
- COMPLETED
- Phase
- PHASE3
FluLaval® Quadrivalent Pregnancy Registry
- Status
- WITHDRAWN
- Phase
- N/A
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3206641A and GSK3206640A Administered in Adults 18 to 64 Years of Age
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Safety of Two Influenza Vaccines in Children and Adolescents 3 to <18 Years of Age at Risk for Influenza-Related Complications
- Status
- COMPLETED
- Phase
- PHASE3
Randomized Controlled Trial of LAIV vs TIV Vaccines in Schools
- Status
- COMPLETED
- Phase
- N/A
Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection
- Status
- WITHDRAWN
- Phase
- PHASE2
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
- Status
- COMPLETED
- Phase
- PHASE3
Safety, Tolerability, and PK of Escalating Doses of Flufirvitide-3 Dry Powder for Inhalation in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) - Year 1, 2009
- Status
- COMPLETED
- Phase
- PHASE4
Phase III Study to Evaluate the Immunogenicity and Safety of MG1109 in Healthy Adult Volunteers
- Status
- COMPLETED
- Phase
- PHASE3
The Impact of a Short Intervention During RSV Prophylaxis on Influenza Vaccination Rate.
- Status
- UNKNOWN
- Phase
- NA
Testing the Use of Prompts to Increase Adolescent Immunization Rates
- Status
- COMPLETED
- Phase
- NA
Reactogenicity, Safety and Immunogenicity of a Live Monovalent A/17/CALIFORNIA/66/395 (H2N2) Influenza Vaccine
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age
- Status
- COMPLETED
- Phase
- PHASE2